ARTICLE | Company News
Par Pharmaceutical, Valeant sales and marketing update
November 6, 2006 8:00 AM UTC
VRX ended an October 2005 deal for PRX to promote VRX's Cesamet nabilone oral capsules in the U.S. (see BioCentury, Nov. 7, 2005). The cannabinoid agonist is approved to treat nausea and vomiting ass...